Urinary phytoestrogens and depression in perimenopausal US women: NHANES 2005-2008

Journal of Affective Disorders

Volumn 156, Issue , 2014, Pages 200-205

  Richard, Aline ^a   Rohrmann, Sabine ^a   Mohler Kuo, Meichun ^a   Rodgers, Stephanie ^b   Moffat, Rebecca ^c   Güth, Uwe ^d   Eichholzer, Monika ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

Cross sectional study; Depression; Isoflavones; Lignans; Perimenopause

Indexed keywords

CROSS-SECTIONAL STUDY; DEPRESSION; ISOFLAVONES; LIGNANS; PERIMENOPAUSE;

CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; ISOFLAVONES; LIGNANS; LOGISTIC MODELS; MIDDLE AGED; NUTRITION SURVEYS; PERIMENOPAUSE; PHYTOESTROGENS; UNITED STATES;

EID: 84895064463     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.12.029     Document Type: Article

References (53)

1. T.N. Akbaraly, E.J. Brunner, J.E. Ferrie, M.G. Marmot, M. Kivimaki, and A. Singh-Manoux Dietary pattern and depressive symptoms in middle age Br. J. Psychiatry 195 2009 408 413
2. G. Bagdy, G. Juhasz, and X. Gonda A new clinical evidence-based gene-environment interaction model of depression Neuropsychopharmacol. Hung. 14 2012 213 220
3. B.T. Baune, I. Adrian, V. Arolt, and K. Berger Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population Psychother. Psychosom. 75 2006 319 326 (Pubitemid 44200480)
4. C. Bodo, and E.F. Rissman New roles for estrogen receptor beta in behavior and neuroendocrinology Front. Neuroendocrinol. 27 2006 217 232 (Pubitemid 43947168)
5. R. Bolanos, A. Del Castillo, and J. Francia Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis Menopause-J. N. Am. Menopause Soc. 17 2010 660 666
6. F. Branca, and S. Lorenzetti Health effects of phytoestrogens Forum Nutr. 2005 100 111 (Pubitemid 43265040)
7. J.T. Bromberger, K.A. Matthews, L.L. Schott, S. Brockwell, N.E. Avis, H.M. Kravitz, S.A. Everson-Rose, E.B. Gold, M. Sowers, and J.F. Randolph Jr. Depressive symptoms during the menopausal transition: the study of women's health across the nation (SWAN) J. Affect. Disord. 103 2007 267 272 (Pubitemid 47445776)
8. J.T. Bromberger, L.L. Schott, H.M. Kravitz, M. Sowers, N.E. Avis, E.B. Gold, J.F. Randolph Jr., and K.A. Matthews Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the study of women's health across the nation (SWAN) Arch. Gen. Psychiatry 67 2010 598 607
9. P. Chedraui, and F.R. Perez-Lopez Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population Climacteric 16 Suppl 1 2013 85 95
10. L.S. Cohen, C.N. Soares, A.F. Vitonis, M.W. Otto, and B.L. Harlow Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles Arch. Gen. Psychiatry 63 2006 385 390
11. M.C. Craig, and D.G. Murphy Estrogen: effects on normal brain function and neuropsychiatric disorders Climacteric 10 Suppl 2 2007 97 104 (Pubitemid 47450834)
12. R.L. de Sousa-Munoz, and R.G. Filizola Efficacy of soy isoflavones for depressive symptoms of the climacteric syndrome Maturitas 63 2009 89 93
13. E.W. Freeman, M.D. Sammel, H. Lin, and D.B. Nelson Associations of hormones and menopausal status with depressed mood in women with no history of depression Arch. Gen. Psychiatry 63 2006 375 382
14. M. Gautam, M. Agrawal, P. Sharma, A.S. Gautam, and S. Gautam Role of antioxidants in generalised anxiety disorder and depression Indian J. Psychiatry 54 2012 244 247
15. Z. Gibbs, S. Lee, and J. Kulkarni What factors determine whether a woman becomes depressed during the perimenopause? Arch. Womens Ment. Health 15 2012 323 332
16. E.B. Gold The timing of the age at which natural menopause occurs Obstet. Gynecol. Clin. N. Am. 38 2011 425 440
17. C.J. Haines, S.F. Yim, T.K. Chung, C.W. Lam, E.W. Lau, M.H. Ng, R. Chin, and D.T. Lee A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women Maturitas 44 2003 207 214 (Pubitemid 36315817)
18. C.D. Humfrey Phytoestrogens and human health effects: weighing up the current evidence Nat. Toxins 6 1998 51 59 (Pubitemid 29012058)
19. N. Ishiwata, M.K. Melby, S. Mizuno, and S. Watanabe New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women Menopause 16 2009 141 148
20. F.N. Jacka, J.A. Pasco, A. Mykletun, L.J. Williams, A.M. Hodge, S.L. O'Reilly, G.C. Nicholson, M.A. Kotowicz, and M. Berk Association of western and traditional diets with depression and anxiety in women Am. J. Psychiatry 167 2010 305 311
21. S.N. Jolley, S. Elmore, K.E. Barnard, and D.B. Carr Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression Biol. Res. Nurs. 8 2007 210 222 (Pubitemid 44893424)
22. S.H. Kennedy Core symptoms of major depressive disorder: relevance to diagnosis and treatment Dialogues Clin. Neurosci. 10 2008 271 277
23. K. Kroenke, R.L. Spitzer, and J.B. Williams The PHQ-9: validity of a brief depression severity measure J. Gen. Intern. Med. 16 2001 606 613 (Pubitemid 32823891)
24. M.F. Kuczmarski, A. Cremer Sees, L. Hotchkiss, N. Cotugna, M.K. Evans, and A.B. Zonderman Higher healthy eating index-2005 scores associated with reduced symptoms of depression in an urban population: findings from the healthy aging in neighborhoods of diversity across the life span (HANDLS) study J. Am. Diet. Assoc. 110 2010 383 389
25. T. Kunisue, S. Tanabe, T. Isobe, K.M. Aldous, and K. Kannan Profiles of phytoestrogens in human urine from several Asian countries J. Agric. Food Chem. 58 2010 9838 9846
26. J.W. Lampe Is equol the key to the efficacy of soy foods? Am. J. Clin. Nutr. 89 2009 1664S 1667S
27. J.W. Lampe, C. Atkinson, and M.A. Hullar Assessing exposure to lignans and their metabolites in humans J. AOAC. Int. 89 2006 1174 1181 (Pubitemid 44972069)
28. M. Lipovac, P. Chedraui, C. Gruenhut, A. Gocan, M. Stammler, and M. Imhof Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts Maturitas 65 2010 258 261
29. M. Maes, Z. Fisar, M. Medina, G. Scapagnini, G. Nowak, and M. Berk New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors Inflammopharmacology 20 2012 127 150
30. L. Manea, S. Gilbody, and D. McMillan Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis CMAJ 184 2012 E191 196
31. B.S. McEwen, and S.E. Alves Estrogen actions in the central nervous system Endocr. Rev. 20 1999 279 307 (Pubitemid 30649809)
32. S.E. McMartin, F.N. Jacka, and I. Colman The association between fruit and vegetable consumption and mental health disorders: evidence from five waves of a national survey of Canadians Prev. Med. 56 2013 225 230
33. N. Mendoza, R. Sanchez-Borrego, M.J. Cancelo, A. Calvo, M.A. Checa, J. Cortes, M.A. Elorriaga, T. Diaz, J.V. Gonzalez, I. Lete, P. Lobo, T. Martinez-Astorquiza, A. Nieto, M.A. Olalla, E. Perez-Campos, R. Porqueras, F. Quereda, A. Salamanca, and E. De La Viuda Position of the Spanish menopause society regarding the management of perimenopause Maturitas 2013
34. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study Lancet 349 1997 1498 1504 (Pubitemid 27216360)
35. C. Nagata, H. Shimizu, R. Takami, M. Hayashi, N. Takeda, and K. Yasuda Serum concentrations of estradiol and dehydroepiandrosterone sulfate and soy product intake in relation to psychologic well-being in peri- and postmenopausal Japanese women Metabolism 49 2000 1561 1564 (Pubitemid 32010843)
36. A. Nanri, Y. Kimura, Y. Matsushita, M. Ohta, M. Sato, N. Mishima, S. Sasaki, and T. Mizoue Dietary patterns and depressive symptoms among Japanese men and women Eur. J. Clin. Nutr. 64 2010 832 839
37. S.O. Nunes, H.O. Vargas, E. Prado, D.S. Barbosa, L.P. de Melo, S. Moylan, S. Dodd, and M. Berk The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence Neurosci. Biobehav. Rev. 37 2013 1336 1345
38. H.B. Patisaul, and W. Jefferson The pros and cons of phytoestrogens Front. Neuroendocrinol. 31 2010 400 419
39. J. Pearce, K. Hawton, F. Blake, D. Barlow, M. Rees, J. Fagg, and J. Keenan Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study J. Psychosom. Res. 42 1997 177 186 (Pubitemid 27129496)
40. A. Ruusunen, S.M. Lehto, T. Tolmunen, J. Mursu, G.A. Kaplan, and S. Voutilainen Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio ischaemic heart disease risk factor study Public Health Nutr. 13 2010 1215 1220
41. M.E. Rybak, M.R. Sternberg, and C.M. Pfeiffer Sociodemographic and lifestyle variables are compound- and class-specific correlates of urine phytoestrogen concentrations in the U.S. population J. Nutr. 143 2013 986S 994S
42. S. Salim, G. Chugh, and M. Asghar Inflammation in anxiety Adv. Protein Chem. Struct. Biol. 88 2012 1 25
43. R.S. Smith The macrophage theory of depression Med. Hypotheses. 35 1991 298 306
44. C.N. Soares, O.P. Almeida, H. Joffe, and L.S. Cohen Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial Arch. Gen. Psychiatry 58 2001 529 534 (Pubitemid 32523731)
45. R.L. Spitzer, K. Kroenke, and J.B. Williams Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire JAMA 282 1999 1737 1744 (Pubitemid 29533604)
46. J.W. Studd A guide to the treatment of depression in women by estrogens Climacteric 14 2011 637 642
47. N. Sumien, K. Chaudhari, A. Sidhu, and M.J. Forster Does phytoestrogen supplementation affect cognition differentially in males and females? Brain Res. 1514 2012 123 127
48. A. Thapar, S. Collishaw, D.S. Pine, and A.K. Thapar Depression in adolescence Lancet 379 2012 1056 1067
49. R. Trevoux, J. De Brux, M. Castanier, K. Nahoul, J.P. Soule, and R. Scholler Endometrium and plasma hormone profile in the peri-menopause and post-menopause Maturitas 8 1986 309 326 (Pubitemid 17030400)
50. L. Valentin-Blasini, B.C. Blount, S.P. Caudill, and L.L. Needham Urinary and serum concentrations of seven phytoestrogens in a human reference population subset J. Expo. Anal. Environ. Epidemiol. 13 2003 276 282 (Pubitemid 36999366)
51. Y.T. van der Schouw, L. Sampson, W.C. Willett, and E.B. Rimm The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in U.S. men J. Nutr. 135 2005 260 266 (Pubitemid 40194488)
52. Y.F. Wang, Z.K. Xu, D.H. Yang, H.Y. Yao, B.S. Ku, X.Q. Ma, C.Z. Wang, S.L. Liu, and S.Q. Cai The antidepressant effect of secoisolariciresinol, a lignan-type phytoestrogen constituent of flaxseed, on ovariectomized mice J. Nat. Med. 67 2013 222 227
53. M. Wiacek, W. Hagner, and I.Z. Zubrzycki Measures of menopause driven differences in levels of blood lipids, follicle-stimulating hormone, and luteinizing hormone in women aged 35-60 years: national health and nutrition examination survey III and national health and nutrition examination survey 1999-2002 study Menopause 18 2011 60 66